Decompressive hemicraniectomy and cranioplasty using subcutaneously preserved autologous bone flaps versus synthetic implants: perioperative outcomes and cost analysis.

Autor: Dowlati E; 2Department of Neurosurgery, MedStar Georgetown University Hospital, and., Pasko KBD; 1Georgetown University School of Medicine., Molina EA; 1Georgetown University School of Medicine., Felbaum DR; 2Department of Neurosurgery, MedStar Georgetown University Hospital, and.; 3Department of Neurosurgery, MedStar Washington Hospital Center, Washington, DC., Mason RB; 3Department of Neurosurgery, MedStar Washington Hospital Center, Washington, DC., Mai JC; 2Department of Neurosurgery, MedStar Georgetown University Hospital, and.; 3Department of Neurosurgery, MedStar Washington Hospital Center, Washington, DC., Nair MN; 2Department of Neurosurgery, MedStar Georgetown University Hospital, and., Aulisi EF; 3Department of Neurosurgery, MedStar Washington Hospital Center, Washington, DC., Armonda RA; 2Department of Neurosurgery, MedStar Georgetown University Hospital, and.; 3Department of Neurosurgery, MedStar Washington Hospital Center, Washington, DC.
Jazyk: angličtina
Zdroj: Journal of neurosurgery [J Neurosurg] 2022 Apr 29; Vol. 137 (6), pp. 1831-1838. Date of Electronic Publication: 2022 Apr 29 (Print Publication: 2022).
DOI: 10.3171/2022.3.JNS212637
Abstrakt: Objective: It has not been well-elucidated whether there are advantages to preserving bone flaps in abdominal subcutaneous (SQ) tissue after decompressive hemicraniectomy (DHC), compared to discarding bone flaps. The authors aimed to compare perioperative outcomes and costs for patients undergoing autologous cranioplasty (AC) after DHC with the bone flap preserved in abdominal SQ tissue, and for patients undergoing synthetic cranioplasty (SC).
Methods: A retrospective review was performed of all patients undergoing DHC procedures between January 2017 and July 2021 at two tertiary care institutions. Patients were divided into two groups: those with flaps preserved in SQ tissue (SQ group), and those with the flap discarded (discarded group). Additional analysis was performed between patients undergoing AC versus SC. Primary end points included postoperative and surgical site complications. Secondary endpoints included operative costs, length of stay, and blood loss.
Results: A total of 248 patients who underwent DHC were included in the study, with 155 patients (62.5%) in the SQ group and 93 (37.5%) in the discarded group. Patients in the discarded group were more likely to have a diagnosis of severe TBI (57.0%), while the most prevalent diagnosis in the SQ group was malignant stroke (35.5%, p < 0.05). There were 8 (5.2%) abdominal surgical site infections and 9 (5.8%) abdominal hematomas. The AC group had a significantly higher reoperation rate (23.2% vs 12.9%, p = 0.046), with 11% attributable to abdominal reoperations. The average cost of a reoperation for an abdominal complication was $40,408.75 ± $2273. When comparing the AC group to the SC group after cranioplasty, there were no significant differences in complications or surgical site infections. There were 6 cases of significant bone resorption requiring cement supplementation or discarding of the bone flap. Increased mean operative charges were found for the SC group compared to the AC group ($72,362 vs $59,726, p < 0.001).
Conclusions: Autologous bone flaps may offer a cost-effective option compared to synthetic flaps. However, when preserved in abdominal SQ tissue, they pose the risk of resorption over time as well as abdominal surgical site complications with increased reoperation rates. Further studies and methodologies such as cryopreservation of the bone flap may be beneficial to reduce costs and eliminate complications associated with abdominal SQ storage.
Databáze: MEDLINE